Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

P73 G4C14-to-A4T14 polymorphism is associated with survival in advanced non-small cell lung cancer patients.

Ge L, Yang Y, Sun Y, Xu W, Lu D, Su B.

Thorac Cancer. 2017 Mar;8(2):63-72. doi: 10.1111/1759-7714.12397. Epub 2017 Jan 30.

2.

p73 expression is regulated by ribosomal protein RPL26 through mRNA translation and protein stability.

Zhang M, Zhang J, Yan W, Chen X.

Oncotarget. 2016 Nov 29;7(48):78255-78268. doi: 10.18632/oncotarget.13126.

3.

Oncogenic Intra-p53 Family Member Interactions in Human Cancers.

Ferraiuolo M, Di Agostino S, Blandino G, Strano S.

Front Oncol. 2016 Mar 31;6:77. doi: 10.3389/fonc.2016.00077. eCollection 2016. Review.

4.

DNA repair and aging: the impact of the p53 family.

Nicolai S, Rossi A, Di Daniele N, Melino G, Annicchiarico-Petruzzelli M, Raschellà G.

Aging (Albany NY). 2015 Dec;7(12):1050-65. Review.

5.

FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the ΔNp63α protein.

Restelli M, Molinari E, Marinari B, Conte D, Gnesutta N, Costanzo A, Merlo GR, Guerrini L.

Hum Mol Genet. 2015 Aug 1;24(15):4185-97. doi: 10.1093/hmg/ddv151. Epub 2015 Apr 24.

6.

A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity.

Kramer D, Schön M, Bayerlová M, Bleckmann A, Schön MP, Zörnig M, Dobbelstein M.

Cell Death Dis. 2015 Feb 12;6:e1634. doi: 10.1038/cddis.2015.17.

7.

Protein lysine acetylation by p300/CBP.

Dancy BM, Cole PA.

Chem Rev. 2015 Mar 25;115(6):2419-52. doi: 10.1021/cr500452k. Epub 2015 Jan 16. Review. No abstract available. Erratum in: Chem Rev. 2016 Jul 27;116(14 ):8314.

8.

Structure and apoptotic function of p73.

Yoon MK, Ha JH, Lee MS, Chi SW.

BMB Rep. 2015 Feb;48(2):81-90. Review.

9.

Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.

Ozaki T, Sugimoto H, Nakamura M, Hiraoka K, Yoda H, Sang M, Fujiwara K, Nagase H.

FEBS J. 2015 Jan;282(1):114-28. doi: 10.1111/febs.13108. Epub 2014 Nov 10.

10.

TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.

Chen D, Ming L, Zou F, Peng Y, Van Houten B, Yu J, Zhang L.

Oncotarget. 2014 Sep 30;5(18):8107-22.

11.

Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus.

Schipper H, Alla V, Meier C, Nettelbeck DM, Herchenröder O, Pützer BM.

Oncotarget. 2014 Aug 15;5(15):5893-907.

12.

Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.

Stephens RS, Servinsky LE, Rentsendorj O, Kolb TM, Pfeifer A, Pearse DB.

Am J Physiol Cell Physiol. 2014 Mar 15;306(6):C559-69. doi: 10.1152/ajpcell.00375.2012. Epub 2014 Jan 8.

13.

Lysine-specific modifications of p53: a matter of life and death?

Marouco D, Garabadgiu AV, Melino G, Barlev NA.

Oncotarget. 2013 Oct;4(10):1556-71. Review.

14.

TAp73 protein stability is controlled by histone deacetylase 1 via regulation of Hsp90 chaperone function.

Zhang J, Xu E, Chen X.

J Biol Chem. 2013 Mar 15;288(11):7727-37. doi: 10.1074/jbc.M112.429522. Epub 2013 Jan 29.

15.

Tumour suppressor genes in chemotherapeutic drug response.

Lai D, Visser-Grieve S, Yang X.

Biosci Rep. 2012 Aug;32(4):361-74. doi: 10.1042/BSR20110125. Review.

16.

p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stability.

Yan W, Zhang J, Zhang Y, Jung YS, Chen X.

Mol Cell Biol. 2012 Jul;32(13):2336-48. doi: 10.1128/MCB.00215-12. Epub 2012 Apr 16.

17.

Graft-versus-host disease-related cytokine-driven apoptosis depends on p73 in cytokeratin 15-positive target cells.

Zhan Q, Korngold R, Lezcano C, McKeon F, Murphy GF.

Biol Blood Marrow Transplant. 2012 Jun;18(6):841-51. doi: 10.1016/j.bbmt.2012.02.004. Epub 2012 Mar 30.

18.

E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.

Saha A, Lu J, Morizur L, Upadhyay SK, Aj MP, Robertson ES.

PLoS Pathog. 2012;8(3):e1002573. doi: 10.1371/journal.ppat.1002573. Epub 2012 Mar 15.

19.

Regulation of p73 activity by post-translational modifications.

Conforti F, Sayan AE, Sreekumar R, Sayan BS.

Cell Death Dis. 2012 Mar 15;3:e285. doi: 10.1038/cddis.2012.27. Review.

20.

Relative expression of TAp73 and ΔNp73 isoforms.

Conforti F, Yang AL, Agostini M, Rufini A, Tucci P, Nicklison-Chirou MV, Grespi F, Velletri T, Knight RA, Melino G, Sayan BS.

Aging (Albany NY). 2012 Mar;4(3):202-5.

Supplemental Content

Support Center